FEKAL KALPROTEKTINNING ICHAK KASALLIKLARINING KOMPLEKS TASHXISOTIDAGI O’RNI
Keywords:
Kalit so'zlar: fekal kalprotektin; immunoferment tahlili (IFT); yallig'lanish; ichak.Abstract
Annotatsiya. Maqolada ichak kasalliklarini kompleks diagnostikasida
noinvaziv laboratoriya usuli — fekal kalprotektin testi haqida daliliy asoslar tahlil
qilinadi. Fekal kalprotektin testi ichak kasalliklarini aniqlashda eng istiqbolli va
qulay usullardan biri bo'lib, ayniqsa, ichak yallig’lanish kasalliklari (YIK) kabi
kasalliklar uchun juda muhim hisoblanadi.
References
1. Sartor R. B., Sandborn W. I. Kirsner’s inflammatory bowel diseases. —
6th ed. — London: Saunders, 2004. — 754 p.
2. Dale I. et al. Distribution of a new myelomonocytic antigen (L1) in
human peripheral blood leukocytes // Am. J. Clin. Pathology. — 1985. — Vol. 84.
— Р. 24 – 34
3. Fagerhol M. K. et al. Calprotectin (The L1 leukocyte protein) //
4. V. L. Smith and J. R. Dedman (eds.) Stimulus response coupling: The
role of intracellular calcium-binding proteins. — CRC Press, Boca Raton, 1990.
— 187 – 210 р.
5. Isaksen В., Fagerhol M. K. Calprotectin inhibits matrix metallopro-
teinases by sequestration of zinc // J. Clin. Pathol: Mol. Pathol. — 2001. — Vol. 54.
— Р. 289 – 292.
6. Steinbakk M. et al. Antimicrobial actions of calcium binding leukocyte L1
protein, calprotectin // Lancet. — 1990. — Vol. 336. — Р. 763 – 765.
7. Roseth A. G. et al. Assessment of the neutrophil dominating protein
calprotectin in faeces // Scand. J. Gastroenterol. — 1992. — Vol. 27. — Р. 793 –
798.
8. Patrick F van Rheenen. Faecalcalprotectin for screening of patients
with suspected inflammatory bowel disease: diagnostic meta-analysis paediatric
gastroenterologist // BMJ. — 2010. — Vol. 341. — Р. 3369.
9.Kennedy N. A. et al. Elevated faecalcalprotectin predicts disease
progression in Crohn’s disease: WWW Ecco — IBD.ЕС
10.Gisbert J. P. Fecal calprotectin and lactoferrin for the prediction of
inflammatory bowel disease relapse / J. P. Gisbert, F. Bermejo, J. L. Perez- Calle [et
al.] // Inflamm. Bowel Dis. — 2009. — Vol. 15. — Р. 1190 – 1198.
11.Ferreiro R. et al. Use of faecalcalprotectin as predictor of relapse in pa-
tients under maintenance treatment with infliximab: WWW Ecco — IBD.ЕС
12. World Gastroenterology Organisation Global Guidelines (WGO) Practice
Guideline — Inflammatory bowel disease: a global perspec- tive — June 2009:
www WGO.
13. Gert Van Assche, Dignass A., Panes J. et al. The second European
evidence-based consensus on the diagnosis and management of Crohn’s disease:
Definitions and diagnosis // J. Crohn’s and Colitis. — 2010. — Vol. 4. — Р. 7 – 27
14. Долгих Т. И., Войтович М. А., Галилейская С. Б., Лазаре- ва Л.
И. Особенности диагностики кишечной инфекции, вызван- ной
Escherichiacoli О157, осложненной гемолитико-уремическим синдромом у
детей раннего возраста в Омской области // Вестн. Уральской мед. акад.
науки. — 2009. — № 4 (27). — С. 119 – 120.
15.U. von Arnim et al. Faecalcalprotectin: Useful for clinical differen- tiation
of microscopic colitis and irritable bowel syndrome? // WWW Ecco — IBD.ЕС.
